About Sound Pharma
Sound Pharma is a Healthcare company based in Seattle (United States) founded in 2002. Novel treatments for hearing loss are developed using SPI technology. Sound Pharma has raised $25.19 million across 11 funding rounds from investors including Cystic Fibrosis Foundation. The company has 1 employees. Its chief executive, as recorded, is Jonathan Kil. Sound Pharma offers products and services including Otoprotection, Chemoprotection, and Regeneration. Its focus areas include Life Sciences, ENT Disorders and Drugs. Its legal entity is SOUND PHARMACEUTICALS INC. Its competitors include Lyra Therapeutics, Decibel Therapeutics and Perceive Bio; 3 of its 3 listed competitors have raised funding.
Company details
Sound Pharma was founded in 2002 and is based in Seattle, United States. Focus is placed on the biotechnology sector, where otologic drug development occurs for sensorineural inner ear diseases. The SPI platform is utilized to advance treatments, including SPI-1005 in clinical trials for acute noise-induced hearing loss and Menieres disease, as well as SPI-3005 for chemotherapy- and aminoglycoside-induced ototoxicity in phase 1.
- Headquarters Seattle, United States
- Employees 1
- SectorsHealthcare
- Website soundpharma.com
- Social LinkedIn
- Legal Name Sound Pharmaceuticals Inc.
- Total Equity Funding$25.19M (USD)
in 11 rounds
- Latest Funding Round$8.41M (USD), Series B
Jun 2018
- Investors
- Employee Count1
Products & Services of Sound Pharma
Sound Pharma offers a comprehensive portfolio of products and services, including Otoprotection, Chemoprotection, and Regeneration.
Oral treatments for preventing acute and chronic hearing loss.
Oral combination for treating acute ototoxicity effects.
Locally delivered options for restoring hearing function.
Funding Insights of Sound Pharma
Sound Pharma has successfully raised a total of $25.19M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $8.41 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.19M
- Total Rounds 11
- Last Round Series B — $8.41M
- First Round $160,000
(Dec 2002)
- Investors Count 1
Latest 10 of 11 funding rounds of Sound Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2018 | $8.41M | Series B | – | – | – |
| Mar 2017 | $1.6M | Grant | – | – | |
| Sep 2016 | $4.1M | Series A | – | – | – |
| Oct 2013 | $7.56M | Series A | – | – | – |
| Dec 2012 | $1.52M | Seed | – | – | – |
| Aug 2009 | $2.1M | Grant | – | – | – |
| Jan 2008 | $1M | Debt – Convertible | – | – | – |
| Dec 2007 | $1M | Series A | – | – | – |
| Dec 2007 | Debt – Conventional | – | – | – | |
| Jul 2006 | $2.6M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Sound Pharma
Sound Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cystic Fibrosis Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Research funding and support for cystic fibrosis patients are provided. | 1955 | cff.org | Bethesda, United States |
Investor details for Sound Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sound Pharma
1 people are tracked at Sound Pharma (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Jonathan Kil | CEO & CMO | Leadership |
Complete people profiles for Sound Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sound Pharma
3 dated milestones of Sound Pharma across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Sound Pharma is founded.
- Funding First funding round of $160K.
- Funding Latest funding round, Series B, of $8.4M.
Competitors of Sound Pharma
Sound Pharma has 3 listed competitors in our database, 3 of them funded. They include Lyra Therapeutics, Decibel Therapeutics and Perceive Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lyratherapeutics.com | 2005 | Watertown, United States | $127.61M | 75 | Small molecule therapeutics for ENT diseases are developed. | |
| decibeltx.com | 2015 | Cambridge, United States | $169.53M | 62 | Medicines are developed to protect, repair, and restore hearing capacity. | |
| perceivebio.com | 2021 | San Francisco, United States | $78M | Developer of therapeutics to treat diabetes and eye diseases |
Detailed competitors of Sound Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sound Pharma
The website of Sound Pharma (soundpharma.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▼ 8.3% vs previous month
Websites whose visitors overlap most with Sound Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| omeros.com | 100% | 15.6K | #1,695,799 | View details | |
| talus.bio | 100% | 4.4K | #4,306,649 | View details | |
| alpenglowbiosciences.com | 100% | 3.7K | #4,504,338 | View details | |
| pharmain.com | 99% | 1.5K | #11,691,207 | View details | |
| faradaypharma.com | 98% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Sound Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in ENT Disorders
3 companies that operate in the same segment as Sound Pharma (ENT Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medicines are developed to protect, repair, and restore hearing capacity. | 2015 | Cambridge, Massachusetts, United States | USD 169.53 M | 62 | ||
Small molecule therapeutics for ENT diseases are developed. | 2005 | Watertown, United States | USD 127.61 M | USD 1.53 M | 30 | |
Hearing aids are supplied for individuals with hearing disabilities. | 2010 | San Jose, California, United States | USD 216.58 M | 45 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sound Pharma
Complete news archive for Sound Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sound Pharma
Sound Pharma was founded in 2002.
Sound Pharma is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Jonathan Kil is the CEO of Sound Pharma, as recorded in our data.
Sound Pharma is a funded company, having raised a total of $25.19M across 11 funding rounds to date. The company's 1st funding round was a Series A of $2.6M, raised on Dec 2002.
Sound Pharma has 1 employees.
Sound Pharma was founded in 2002 and is based in Seattle, United States. Focus is placed on the biotechnology sector, where otologic drug development occurs for sensorineural inner ear diseases. The SPI platform is utilized to advance treatments, including SPI-1005 in clinical trials for acute noise-induced hearing loss and Menieres disease, as well as SPI-3005 for chemotherapy- and aminoglycoside-induced ototoxicity in phase 1.
Sound Pharma's top competitors include Decibel Therapeutics, Lyra Therapeutics and Perceive Bio.
Sound Pharma offers Otoprotection, Chemoprotection, and Regeneration.
Sound Pharma has 1 investor. Key investors include Cystic Fibrosis Foundation.
Sound Pharma operates through Sound Pharmaceuticals Inc..